Home/Pipeline/Biosimilar Trastuzumab

Biosimilar Trastuzumab

HER2‑positive cancers

PreclinicalActive

Key Facts

Indication
HER2‑positive cancers
Phase
Preclinical
Status
Active
Companies

About Afrigen Biologics

South African biotech delivering affordable vaccines and biosimilars using proprietary biologics platforms.

View full company profile

About Biosidus

Argentina‑based biosimilar leader delivering affordable biologics to emerging markets.

View full company profile

About Strides Pharma

Strides Pharma Science Limited is a multinational pharmaceutical company with a mission to make quality healthcare accessible globally through a hybrid business model spanning regulated and emerging markets. Founded in 1990, it has evolved from a domestic Indian manufacturer into a global leader in complex generics and specialty pharmaceuticals, leveraging a vertically integrated structure with advanced manufacturing and R&D. Key achievements include a 5x increase in Q4 FY2025 net profit, a strategic 'In Africa, For Africa' initiative, and a robust portfolio of USFDA-approved facilities, positioning it for sustainable growth in the global generics market.

View full company profile